Exact Mass: 410.97524480000004
Exact Mass Matches: 410.97524480000004
Found 34 metabolites which its exact mass value is equals to given mass value 410.97524480000004,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Iomazenil
C15H14IN3O3 (411.00798840000004)
Pyridinium-3,5-bisthiocarboxylate mononucleotide; P2TMN; Pyridin-1-ium-3,5-bisthiocarboxylate mononucleotide
Methyl 5-((4-bromo-2-chlorophenyl)amino)-4-fluoro-1-methyl-1H-benzo[d]imidazole-6-carboxylate
disodium 5-[(4-nitro-2-sulphonatophenyl)azo]salicylate
2-Amino-6-(2-(sulfooxy)ethylsulfonyl)naphthalene-1-sulfonic acid
C12H13NO9S3 (410.97524480000004)
sodium 5-hydroxy-6-[(2-hydroxy-5-nitrophenyl)azo]naphthalene-1-sulphonate
C16H10N3NaO7S (411.01371500000005)
6-Bromo-1-carbethoxy-4-methyl-2, 7-dibenz[f,ij]isoquinoline-2,7-dione
C20H14BrNO4 (411.01061440000007)
ethylenediaminetetraacetic acid disodium cobalt salt, hydrate
Iomazenil (123I)
C15H14IN3O3 (411.00798840000004)
C1446 - Radiopharmaceutical Compound > C2124 - Radioconjugate
[(E)-[3-bromo-4-[(2-fluorophenyl)methoxy]-5-methoxyphenyl]methylideneamino]thiourea
(1R,3R)-N-[1-(4-bromophenyl)ethyl]-2,2-dichloro-3-methyl-1-[(S)-methylsulfinyl]cyclopropane-1-carboxamide
2-(3-bromophenyl)-N-(4,5-dihydro-1,3-thiazol-2-yl)quinoline-4-carboxamide
C19H14BrN3OS (411.00408940000005)
2-[[4-(4-Bromophenyl)phenyl]sulfonylamino]-3-methylbutanoic acid
C17H18BrNO4S (411.01398480000006)
4-chloro-3-[(4-chlorophenyl)sulfamoyl]-N-(1H-1,2,4-triazol-5-yl)benzamide
C15H11Cl2N5O3S (410.9959636000001)
(4-Chlorophenyl)-[6,7-dichloro-4-[(dimethylamino)methyl]-5-hydroxy-2-methyl-3-benzofuranyl]methanone
C19H16Cl3NO3 (411.01957160000006)
2,5-dichloro-N-methyl-N-[[3-(3-methylphenyl)-1,2,4-oxadiazol-5-yl]methyl]benzenesulfonamide
2-(4-Bromophenyl)-4-quinolinecarboxylic acid (2-oxo-3-oxolanyl) ester
C20H14BrNO4 (411.01061440000007)
N-[5-[(2,6-dichlorophenyl)methylthio]-1,3,4-thiadiazol-2-yl]-5-methyl-2-pyrazinecarboxamide
BX430
BX430 is a potent and selective noncompetitive allosteric human P2X4 receptor channels antagonist with an IC50 of 0.54 μM. BX430 has species specificity. BX430 is used for chronic pain and cardiovascular disease.
(3s,10s)-5-bromo-9-thia-11,15,20-triazahexacyclo[12.6.1.1³,¹⁰.0²,¹².0³,⁸.0¹⁷,²¹]docosa-1(21),2(12),4,7,14,16,18-heptaene-6,13-dione
2-(3,5-dibromo-4-butoxy-1-hydroxy-4-methoxycyclohexa-2,5-dien-1-yl)ethanimidic acid
C13H19Br2NO4 (410.96807340000004)
2-(4-{1,6-dichloro-3h-pyrrolo[2,3-c]quinolin-4-yl}-1,3-thiazol-2-yl)phenol
C20H11Cl2N3OS (410.99998560000006)